Background To report the feasibility, efficacy, and toxicity of stereotactic body radiotherapy
(SBRT) for the treatment of portal vein tumor thrombosis (PVTT) and/or inferior vena cava …

Background There is currently no worldwide consensus for the management of
hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). We evaluated the …

This study aimed to evaluate the efficacy of stereotactic body radiotherapy (SBRT) compared
with three-dimensional conformal radiotherapy (3DCRT). Forty-three patients with portal …

Background It is unclear whether robotic stereotactic body radiotherapy (SBRT) is superior
to intensity-modulated radiotherapy (IMRT) in advanced hepatocellular carcinoma (HCC) …

The purpose of this study was to evaluate the clinical efficacy, toxicity and adverse effects of
stereotactic body radiotherapy (SBRT) combined with transarterial chemoembolization …

Aim To evaluate the response, survival and safety on 3‐D conformal radiotherapy (3D‐CRT)
for major portal vein tumor thrombosis (PVTT) combined with hepatic arterial infusion …

Background The objectives of this retrospective study was to evaluate the efficacy of
stereotactic body radiation therapy (SBRT) for small non-resectable hepatocellular …

Although the current standard treatment for hepatocellular carcinoma (HCC) with portal vein
tumor thrombosis (PVTT) is sorafenib, many previous studies have established the need for …

BACKGROUND AND PURPOSE: The prognosis of patients with portal vein tumor
thrombosis (PVTT) from hepatocellular carcinoma (HCC) is poor; without treatment, their …

Purpose We performed a meta-analysis and systematic review to compare the radiotherapy
(RT) modalities for hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT) …